MidLantic Urology News Hub

In life, when we are faced with problems, we look for solutions. In medicine, when we receive a diagnosis, we are often fortunate to have treatments available. And for those diagnoses that don’t yet have treatment options developed, we rely on clinical research.

MidLantic Urology’s dedicated providers spend each day working with patients to provide personalized care for an array of urologic conditions, including prostate cancer. In addition to medically supporting patients battling prostate cancer, our support extends outside our offices and into the community.

There are certain things in life that are deemed too taboo for discussion, and female urologic conditions are often high on that list. Our mothers typically have done their jobs to prepare us for menstruation, but when it comes to other conditions that can arise after pregnancy and as we age, women are often left to fend for themselves.

Every year, Philadelphia Magazine assembles its list of Top Docs™, showcasing the region's best physicians in a variety specialties. In 2022, 23 MidLantic Urology physicians were recognized as stand outs in Urology and Radiation Oncology.

Joe Lunardi has built a career on predictions. As the first “bracketologist,” Lunardi developed the art and science of predicting the teams that will be selected in the annual NCAA Men’s Basketball Tournament. He even correctly predicted all 68 teams to appear in the 2013 tournament. But there was one thing he didn’t see coming – his prostate cancer diagnosis.

In late January, Teodora (Tia) Schellato, DO, FACOS, was honored with Medtronic's Center of Excellence designation for her usage and success with the InterStim™ Therapy device, a treatment option for patients looking for more than medication to treat their symptoms of overactive bladder. With this recognition, Dr. Schellato is now the only physician in the Philadelphia region to receive this designation from Medtronic.